Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+5.2%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
+5.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025161.65%
2024-39.16%
202335.38%
2022-1323.51%
2021-88.33%
2020125.16%
2019-113.24%
2018-201.24%
2017-19.16%
201622.38%